LCZ696 (Angiotensin-Neprilysin Inhibition): The New Kid on the Heart Failure Block?

This article provides an extensive review of the mechanism of action, pharmacokinetic properties, clinical efficacy, safety, and tolerability of LCZ696.

Source: Journal of Pharmacy Practice - April 12, 2015 Category: Drugs & Pharmacology Authors: Pham, A. Q., Patel, Y., Gallagher, B. Tags: Continuing Education Article Source Type: research